Literature DB >> 17936097

Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity.

Laurent David1, Virginie Dulong, Didier Le Cerf, Lionel Cazin, Marek Lamacz, Jean-Pierre Vannier.   

Abstract

The extracellular polysaccharide hyaluronan (HA) controls cell migration, differentiation and proliferation, and contributes to the invasiveness of human cancers. In order to investigate the sensitivity of cancer cells to antimitotic agents, we developed a cross-linked HA hydrogel, a three-dimensional matrix in which cells can invade and grow. We have studied three cell lines (SA87, NCI-H460 and H460M), from primary tumors and metastases, that migrated into the HA hydrogel and proliferated giving rise to clusters and colonies. Concurrently, we studied the growth of these cell lines in a usual monolayer culture system. In these two models, increasing concentrations of doxorubicin and 5-fluorouracil were evaluated for their ability to inhibit tumor cell growth and colony formation. Taken together, our data suggest that the cancer cells were more resistant in the three-dimensional model than in monolayer cell systems. The antimitotic drugs were efficient after 24h of treatment in the monolayer cultures, whereas they were significantly efficient only after one week of incubation in the HA hydrogels. Herein, we show that this cross-linked matrix provides a three-dimensional model particularly appropriate for investigating mechanisms involved in cancer cell line sensitivity to antimitotic drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936097     DOI: 10.1016/j.actbio.2007.08.012

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  27 in total

1.  Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin.

Authors:  Souleymane Abdoul-Azize; Catherine Buquet; Hong Li; Jean-Michel Picquenot; Jean-Pierre Vannier
Journal:  Oncogene       Date:  2018-05-23       Impact factor: 9.867

2.  Microengineering methods for cell-based microarrays and high-throughput drug-screening applications.

Authors:  Feng Xu; JinHui Wu; ShuQi Wang; Naside Gozde Durmus; Umut Atakan Gurkan; Utkan Demirci
Journal:  Biofabrication       Date:  2011-07-01       Impact factor: 9.954

3.  Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems.

Authors:  Luciana Meli; Eric T Jordan; Douglas S Clark; Robert J Linhardt; Jonathan S Dordick
Journal:  Biomaterials       Date:  2012-09-19       Impact factor: 12.479

4.  Direct effect of bevacizumab on glioblastoma cell lines in vitro.

Authors:  Thomas Simon; Bérénice Coquerel; Alexandre Petit; Yusra Kassim; Elise Demange; Didier Le Cerf; Valérie Perrot; Jean-Pierre Vannier
Journal:  Neuromolecular Med       Date:  2014-08-13       Impact factor: 3.843

Review 5.  Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges.

Authors:  Sara I Montanez-Sauri; David J Beebe; Kyung Eun Sung
Journal:  Cell Mol Life Sci       Date:  2014-10-02       Impact factor: 9.261

Review 6.  Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents.

Authors:  Sreenath V Sharma; Daniel A Haber; Jeff Settleman
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

7.  Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-co-glycolic acid) microsphere.

Authors:  Sun-Woong Kang; You Han Bae
Journal:  Biomaterials       Date:  2009-05-15       Impact factor: 12.479

8.  Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells.

Authors:  Lisa A Gurski; Amit K Jha; Chu Zhang; Xinqiao Jia; Mary C Farach-Carson
Journal:  Biomaterials       Date:  2009-08-19       Impact factor: 12.479

Review 9.  A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening.

Authors:  Christopher Heylman; Agua Sobrino; Venktesh S Shirure; Christopher Cw Hughes; Steven C George
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-16

10.  Modeling Ewing sarcoma tumors in vitro with 3D scaffolds.

Authors:  Eliza Li Shan Fong; Salah-Eddine Lamhamedi-Cherradi; Emily Burdett; Vandhana Ramamoorthy; Alexander J Lazar; F Kurtis Kasper; Mary C Farach-Carson; Deeksha Vishwamitra; Elizabeth G Demicco; Brian A Menegaz; Hesham M Amin; Antonios G Mikos; Joseph A Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.